MedtechVISION 2016: Global Medtech

On September 13th, 2016, the sixth annual MedtechVISION conference was held, bringing together 240 women in medtech, medicine, venture capital, and related fields. The interactive discussion focused on Global Medtech.

Increased focus in the medtech industry on global markets in recent years has led to exciting innovation and evolution in product development, commercialization models and even funding strategies. MedtechVISION2016 explored opportunities for medtech to continue to thrive globally.

Kim Popovits, CEO of Genomic Health, was honored as the recipient of the 2016 Ferolyn Powell Award.

Agenda:
7:00 AM – 8:00 PM PDT

Location:
Rosewood Sand Hill
2825 Sand Hill Rd
Menlo Park, CA 94025

Breakfast
7:00 – 8:00 AM

Welcome & Introduction to Theme
8:00 – 8:30 AM

Patient Keynote: Regina Holliday
8:30 – 9:15 AM
Patient Rights Activist, Artist, Author, Speaker & Founder of the Walking Gallery

Break
9:15 – 9:30 AM

Panel 1: Driving Innovation to Meet Global Needs
9:30 – 10:30 AM

With an increased focus on markets outside of the United States in the medtech industry, a unique approach is required to identify unmet needs for global regions, create solutions that are compatible with the training and infrastructure within the global environment, and develop products that are effective and affordable. This panel is focused on novel approaches that large companies, small companies, and non-profit organizations have developed to address global opportunities.

• Moderator
  Terri Burke, Vice President, Edwards Lifesciences

• Panelists
  Sanaz Saatchi, R&D Engineering Program Manager, Medtronic
  Josie Everett, Executive Director, Heart to Heart International Children’s Medical Alliance
  Anula K. Jayasuriya, MD, PhD, Managing Director, InvAscent
  Carolyn Yarina, CEO, Sisu Global Health
  Jane Chen, CEO and Co-Founder, Embrace Innovations

Panel 2: International Commercialization & Creative Models for Execution
10:30 – 11:30 AM

Global commercial success in Medtech requires multiple applications of singular technology platforms offered to diverse market segments based on regional needs. This panel will explore strategies for commercialization in developed and emerging markets, with case examples from commercial medtech business leaders with international experience.

• Moderator
  Ritu Kamal, Director of Product, CellMax Life

• Panelists
  June Fujimoto, Head of Marketing, Bloomlife
  Sandra Lesenfants, Vice President General Manager, endoVenous Franchise, Aortic Peripheral Vascular at Medtronic
  Cecile Ferracci, General Manager, EU at Endologix
  Ruchika Singhal, VP of International at CR Bard

Lunch
11:30 AM – 12:30 PM

Executive Interview: Erica Rogers
12:30 – 1:15 PM
President and CEO Silk Road Medical. Former COO Medicines360, Former CEO Allux Medical, Founder & Former CEO Visiogen

Panel 3: Global Payment Models: Where to Start
1:15 – 2:15 PM

Knowing the path to reimbursement can vary by country. How can a company maximize its investments by spending on activities that drive the most value? This panel will walk through two case studies for use in defining key success factors in global market access.

• Moderator
  Mika Nishimura, Operational Partner, Gilde Healthcare Partners
• Panelists
  Katja Schroeder, Senior Consultant, Kalms & Partner Consulting
  Leslie Stephens, Director, Health Economics and Reimbursement, Abbott Vascular
  Anne Smart, Director, Navigant Life Sciences
  Naomi Soffa, Director of Market Access, Quorum Consulting

Break
2:15 – 2:45 PM

Ferolyn Powell Award
2:45 – 3:15 PM

Panel 4: Thinking Globally: New Opportunities for Funding and Markets
3:15 – 4:15 PM

The last several years have proved challenging for medtech companies. Shifting climates for public and private reimbursement, coupled with a weaker appetite for medtech investments within the venture capital community have made it especially difficult for early-stage companies in the US to secure funding. This environment has led many medtech companies to seek alternative methods of funding, including international funding or earlier entry to global markets as a revenue source. This panel will explore recent trends in funding, market mechanisms, and launch strategies outside the US.

• Moderator
  Stacy Enxing Seng, Venture Partner, Lightstone Ventures

• Panelists
  Lisa Wipperman Heine, Chief Operating Officer at Mitralign
  Milena Adamian, MD, Founder and Managing Partner, Azimuth Ventures/Life Sciences Angel Network
  Renee Ryan, Vice President, Venture Investments, Johnson & Johnson Innovation

End of day Keynote: Jane Coyne, Director of Tuberculosis Programs, Office of the United Nations Special Envoy on Tuberculosis, UCSF, Former Program Manager, MSF/Doctors Without Borders
4:15 – 5:15 PM
Director of Tuberculosis Programs, Office of the United Nations Special Envoy on Tuberculosis, UCSF, Former Program Manager, MSF/Doctors Without Borders

Closing
5:15 – 5:30 PM

Networking Wine Reception & Dinner
5:30 – 7:30 PM

Sponsors